Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context

• Published in: Revista Brasileira de Oftalmologia Vol. 78; no. 1; pp. 7 - 10
• Main Authors: Rodrigues, Bárbara Emilly Matos, Branco, André Barbosa Castelo, Mendes, Igor Barbosa, Koch, Camila Ribeiro, Amaral, Bruno Andrade, Costa, Lindemberg Assunção
• Format: Journal Article
• Language: English
• Published: Sociedade Brasileira de Oftalmologia 01-01-2019
• Subjects: Acuidade visual; Anticorpos monoclonais/uso terapêutico; Degeneração macular/terapia; Neovascularização retiniana
• ISSN: 0034-7280; 1982-8551
• DOI: 10.5935/0034-7280.20190002

Abstract Objective: The primary objective of the study is to evaluate, in a population in the state of Bahia, Brazil, the impact of ranibizumab in best-corrected visual acuity of patients with macular disease and macular edema. Methods: This study did a retrospective and observational assessment visual acuity of the group of patients followed at the Professor Edgard Santos University Hospital and Oftalmodiagnose Eye Hospital in 2011 and 2012 in a real life context. Results: The impact on sample patientes post-treatment demonstrated favorable outcome with an increase in visual acuity of 32%, which means improvement of more than one line in the snellem chart. Conclusion: Improvement in visual acuity of this group was observed from baseline to the end of follow up in a real-life context.